TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
MNKD

MannKind Corp

Healthcare · Biotechnology

3.60$ +0.8% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

MannKind Corp (MNKD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 349 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement MNKD
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 175 12 28 63 65 75 100 199 286 349
170 140 50 17 20 28 25 39 57 63 77 61
0.0 -140 125 -5.5 7.4 35 41 37 42 136 209 288
100 30 15 14 8.7 6.9 6.2 12 20 31 46 66
79 108 27 75 80 75 23 32 38 43 94 144
180 204 60 89 88 80 88 84 106 128 136 249
-180 -345 67 -108 -77 -45 -48 -47 -64 8.7 73 39
20 24 18 13 9.4 11 9.5 17 25 25 38 14
-198 -368 126 -117 -87 -52 -57 -81 -87 -10 31 1.4
3.5 12 14 0.1 0.2 7.8 -0.2 11 25 1.6 2.9 -4.5
-198 -368 126 -117 -87 -52 -57 -81 -87 -12 28 5.9
-160 -345 65 -102 -76 -39 -45 -61 -56 15 77 28

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?